Clinical Trial Update: Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Avatar-Directed Chemotherapy for recurrent fallopian tube cancer, ovarian cancer, and primary peritoneal cancer has completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Avatar-Directed Chemotherapy

Snippet

Sponsor: Mayo Clinic | Conditions: Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2024-12-05